Focal dermal hypoplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2092OMIM:305600Q82.8
Who is this for?
Show terms as
1Active trials17Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Focal dermal hypoplasia (FDH), also known as Goltz syndrome or Goltz-Gorlin syndrome, is a rare multisystem genetic disorder primarily affecting the skin, skeletal system, eyes, and face. It is caused by mutations in the PORCN gene, which plays a critical role in Wnt signaling pathways essential for embryonic development. The condition predominantly affects females, as it is typically lethal in males, though rare affected males have been reported (often attributed to somatic mosaicism or Klinefelter syndrome). The hallmark feature of FDH is patchy, thin skin (dermal hypoplasia) with areas where fat tissue herniates through the skin, creating soft yellowish nodules. Skin findings often follow the lines of Blaschko and may include linear streaks of hypo- or hyperpigmentation, telangiectasias, and raspberry-like papillomas of the skin and mucous membranes. Skeletal abnormalities are common and include syndactyly (fusion of fingers or toes), oligodactyly (missing digits), split hand/foot malformation, and limb asymmetry. Ocular manifestations may include colobomas, microphthalmia, and strabismus. Dental anomalies such as enamel hypoplasia, oligodontia, and malocclusion are frequently observed. Additional features can include nail dystrophy, sparse or brittle hair, and occasionally involvement of the kidneys, heart, or gastrointestinal tract. There is no cure for focal dermal hypoplasia, and management is supportive and multidisciplinary. Treatment is tailored to the individual's specific manifestations and may include surgical correction of skeletal anomalies, dermatologic management of skin lesions (including removal of papillomas if symptomatic), ophthalmologic care, dental interventions, and physical or occupational therapy. Regular monitoring by a team including geneticists, dermatologists, orthopedic surgeons, ophthalmologists, and dentists is recommended to address the wide spectrum of potential complications.

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormality of the middle earHP:0000370Short claviclesHP:0000894
Inheritance

X-linked dominant

Carried on the X chromosome; a single copy can cause the condition

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Jun 2007Study of Selected X-linked Disorders: Goltz Syndrome

Baylor College of Medicine

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Focal dermal hypoplasia.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
Other1 trial
Study of Selected X-linked Disorders: Goltz Syndrome
Active
PI: Ignatia B Van den Veyver, MD (Baylor College of Medicine) · Sites: Houston, Texas

Specialists

17 foundView all specialists →
MM
Maria Mansouri
Specialist
1 Focal dermal hypoplasia publication
SR
Sergey Ryabykh
Specialist
1 Focal dermal hypoplasia publication
NA
Nissrine Aboussair
Specialist
1 Focal dermal hypoplasia publication
OH
Oufae Hocar
Specialist
1 Focal dermal hypoplasia publication
SA
Said Amal
Specialist
1 Focal dermal hypoplasia publication
FB
Fatima Zohra Bouzid
Specialist
1 Focal dermal hypoplasia publication
TL
Tungchun Lee
Specialist
1 Focal dermal hypoplasia publication
ML
Mao-Ying Lin
Specialist
1 Focal dermal hypoplasia publication
ZL
Zhimiao Lin
Specialist
1 Focal dermal hypoplasia publication
IM
Ignatia B Van den Veyver, MD
Specialist
PI on 3 active trials1 Focal dermal hypoplasia publication
SM
Stephanie C Hsu, MD
Specialist
PI on 1 active trial
DA
Diana S Aljammal
Specialist
1 Focal dermal hypoplasia publication
SA
Shefa S Almashaqbeh
Specialist
1 Focal dermal hypoplasia publication
HA
Hend M Alharahsheh
Specialist
1 Focal dermal hypoplasia publication
RA
Rana A Alkrimeen
Specialist
1 Focal dermal hypoplasia publication
SA
Samer F Alqudah
Specialist
1 Focal dermal hypoplasia publication
AK
Ali Al Kaissi
Specialist
1 Focal dermal hypoplasia publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Focal dermal hypoplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Focal dermal hypoplasiaForum →

No community posts yet. Be the first to share your experience with Focal dermal hypoplasia.

Start the conversation →

Latest news about Focal dermal hypoplasia

No recent news articles for Focal dermal hypoplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Focal dermal hypoplasia

What is Focal dermal hypoplasia?

Focal dermal hypoplasia (FDH), also known as Goltz syndrome or Goltz-Gorlin syndrome, is a rare multisystem genetic disorder primarily affecting the skin, skeletal system, eyes, and face. It is caused by mutations in the PORCN gene, which plays a critical role in Wnt signaling pathways essential for embryonic development. The condition predominantly affects females, as it is typically lethal in males, though rare affected males have been reported (often attributed to somatic mosaicism or Klinefelter syndrome). The hallmark feature of FDH is patchy, thin skin (dermal hypoplasia) with areas whe

How is Focal dermal hypoplasia inherited?

Focal dermal hypoplasia follows a x-linked dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Focal dermal hypoplasia typically begin?

Typical onset of Focal dermal hypoplasia is neonatal. Age of onset can vary across affected individuals.

Are there clinical trials for Focal dermal hypoplasia?

Yes — 1 recruiting clinical trial is currently listed for Focal dermal hypoplasia on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Focal dermal hypoplasia?

17 specialists and care centers treating Focal dermal hypoplasia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.